Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease ; volume:15 ; number:1 ; day:16 ; month:3 ; year:2023 ; pages:1-14 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (16.3.2023), 1-14, 12.2023
- Creator
-
Pillai, Jagan A.
Bena, James
Bekris, Lynn
Kodur, Nandan
Kasumov, Takhar
Leverenz, James B.
Kashyap, Sangeeta R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01203-y
- URN
-
urn:nbn:de:101:1-2023080609123160546904
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pillai, Jagan A.
- Bena, James
- Bekris, Lynn
- Kodur, Nandan
- Kasumov, Takhar
- Leverenz, James B.
- Kashyap, Sangeeta R.
- SpringerLink (Online service)
Other Objects (12)
Dementia / Alzheimer's Disease
A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Predicting Alzheimer’s progression in MCI: a DTI-based white matter network model
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Microglial immunophenotype in dementia with Alzheimer’s pathology
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer’s disease and vascular dementia
Statins and cognitive decline in patients with Alzheimer’s and mixed dementia: a longitudinal registry-based cohort study
Dementia / Alzheimer's Disease
A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Predicting Alzheimer’s progression in MCI: a DTI-based white matter network model
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Microglial immunophenotype in dementia with Alzheimer’s pathology
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer’s disease and vascular dementia
Statins and cognitive decline in patients with Alzheimer’s and mixed dementia: a longitudinal registry-based cohort study
Dementia / Alzheimer's Disease
A systematic review of cognitive decline in dementia with Lewy bodies versus Alzheimer’s disease
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Predicting Alzheimer’s progression in MCI: a DTI-based white matter network model
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Microglial immunophenotype in dementia with Alzheimer’s pathology
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Comparison of subjective cognitive decline and polygenic risk score in the prediction of all-cause dementia, Alzheimer’s disease and vascular dementia